Venrock Partners, L.P., 10% Owner at Bellerophon Therapeutics, Inc. (BLPH), bought 210,000 shares at $1.23 ($252K) on 2018-09-14, disclosed to the SEC on 2018-09-17.
Open-market purchase of $252k BLPH by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.19 | 75,000 | $89K | 35.4% |
| 2 | $1.23 | 75,000 | $92K | 36.6% |
| 3 | $1.18 | 60,000 | $71K | 28.1% |
| Total | $1.20 avg | 210,000 | $252K | 100% |
| Filing → |
| TRBN | BUY | 2006-10-25 | $76K | — | Filing → |